Novel hybrids of oxoisoaporphine-tryptamine as acetylcholinesterase-induced β-amyloid aggregation inhibitors with improved antioxidant properties
2015 ◽
Vol 80
(2)
◽
pp. 127-136
◽
Keyword(s):
A series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for their antioxidant ability and inhibitory potency on AChE and AChE-induced b-amyloid (Ab) aggregation. The new hybrids consist of a unit of 1-azabenzanthrone and a tryptamine or its derivative, connected through a a,w - alkyldiamide bridge. These hybrids exhibit moderate AChE inhibitory activity with IC50 values in the micromolar range and significant in vitro inhibitory activity toward the AChE-induced Ab aggregation. Moreover, six out of the nine hybrids of this series exhibit a higher oxygen radical absorbance capacity than trolox, which makes them promising anti-Alzheimer drug candidates.
Keyword(s):
2014 ◽
Vol 10
(2)
◽
pp. 2305-2316
◽
2016 ◽
Vol 3
◽
pp. 160-163
Keyword(s):
2007 ◽
Vol 15
(2)
◽
pp. 1160-1167
◽
2016 ◽
Vol 8
(11)
◽
pp. 131
◽
2019 ◽
Vol 2019
◽
pp. 1-7